GLP-1 Receptor Agonists and SGLT2 Inhibitors for the Treatment of Type 2 Diabetes: New Insights and Opportunities for Cardiovascular Protection
The use of sodium-glucose co-transporter-2 inhibitors or glucagon-like peptide-1 receptor agonists versus sulfonylureas and the risk of lower limb amputations: A nation-wide cohort study
They also help break down stubborn fat, improve liver health and promote fat burning
CrossRef Predictors of metabolic dysfunction-associated steatotic liver diseases (MASLD) in Vietnamese population Anh Gia Pham, An Vu-Khanh Le, Yen Thi-Hai Pham, Lanh Sy Nguyen, Huong Lan Nguyen, Nghia Chinh Quach, Thau Manh Cao, Hanh Thi Nguyen, Xuan Thanh Thai, Anh Tuan Luong, Thuy Thi Pham, Hai Duy Vu, Hai Thi-Thanh Tran, Lan Thi Le, Hai Vu, Giang Binh Tran, Hung Scientific Reports .2026;[Epub] CrossRef Lactational WesternStyle Fat Exposure in Mice Programs Metabolic DysfunctionAssociated Steatotic Liver Disease (MASLD) in Male Offspring Amy Y
Combined, they deliver both instant results and sustained healing